The onset of REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) and RoHS (Restriction of Hazardous Substances Directive) are expected to transform how medical device companies manage their supply chains.  The effects of both as well as other environmental regulations on device companies and their supply chains is detailed in a white paper provided by IHS, Inc, Englewood, CO.